Bio-ink structures and methods of producing the same

US12404413B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12404413-B2
Application numberUS-201816153501-A
CountryUS
Kind codeB2
Filing dateOct 5, 2018
Priority dateOct 5, 2018
Publication dateSep 2, 2025
Grant dateSep 2, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Bio-ink comprising freeze-dried cells, methods of making a living structure from a bio-ink material of freeze-dried cells, and methods of using the living structure for biosensing, tissue regeneration, environment sensing, drug discovery, catalysis, and/or clinical implementation are described herein.

First claim

Opening claim text (preview).

We claim: 1. A bio-ink comprising: a first filler component comprising freeze-dried cells, wherein the first filler component of freeze-dried cells has a cell density of at least about 10 vol % or more of the total volume of the bio-ink, and a second filler component comprising nanocellulose crystalline powder, wherein the bio-ink is configured to be used for bioprinting three-dimensional structures including living cells. 2. The bio-ink of claim 1 , wherein the first filler component of freeze-dried cells are microbes, wherein the microbes are selected from the group consisting of bacteria, algae, fungi, protozoa, and a mixture thereof. 3. The bio-ink of claim 1 , wherein the first filler component of freeze-dried cells has a cell density of at least about 20 vol % or more of the total volume of the bio-ink. 4. The bio-ink of claim 1 , wherein the first filler component of freeze-dried cells has a cell density of at least about 40 vol % or more of the total volume of the bio-ink. 5. The bio-ink of claim 1 , wherein the first filler component of freeze-dried cells has a cell density of at least about 60 vol % or more of the total volume of the bio-ink. 6. The bio-ink of claim 1 , wherein the first filler component of freeze-dried cells has a cell density of at least about 80 vol % or more of the total volume of the bio-ink. 7. A bio-ink comprising: a first filler component comprising freeze-dried cells, wherein the first filler component of freeze-dried cells has a cell density of at least about 10 wt % of the total weight of the bio-ink and a second filler comprising nanocellulose crystalline powder, wherein the bio-ink is configured to be used for bioprinting three-dimensional structures including living cells. 8. The bio-ink of claim 7 , wherein the first filler component of freeze-dried cells are microbes, and wherein the microbes are selected from the group consisting of bacteria, algae, fungi, protozoa, and a mixture thereof. 9. The bio-ink of claim 7 , wherein the first filler component of freeze-dried cells has a cell density of at least about 20 wt % or more of the total weight of the bio-ink. 10. The bio-ink of claim 7 , wherein the first filler component of freeze-dried cells has a cell density of at least about 40 wt % or more of the total weight of the bio-ink. 11. The bio-ink of claim 7 , wherein the first filler component of freeze-dried cells has a cell density of at least about 60 wt % or more of the total weight of the bio-ink. 12. The bio-ink of claim 7 , wherein the first filler component of freeze-dried cells has a cell density of at least about 80 wt % or more of the total weight of the bio-ink. 13. A bio-ink comprising: a first filler component comprising freeze-dried cells, wherein the first filler component of freeze-dried cells has a cell density of at least about 10 vol % or more of the total volume of the bio-ink, a second filler component selected from the group consisting of nanocellulose, cellulose nanocrystals (CNC), cellulose nanofibrils (CNF), and nanocellulose crystalline powder, wherein the bio-ink is configured to be used for bioprinting three-dimensional structures including living cells, and a binder comprising an oligomer, monomer, or a combination thereof, wherein the binder is configured to form a polymer when the bio-ink is used for bio-printing the three-dimensional structures including living cells. 14. The bio-ink of claim 13 , wherein the binder comprises styrene, methacrylate, vinyl alcohol, polyisobutylene, glycerol, polypropylene, or polyethylene glycol dimethacrylate. 15. The bio-ink of claim 13 , further comprising a photo-initiator configured to initiate photopolymerization of the binder upon irradiation with light. 16. The bio-ink of claim 15 , wherein the photo-initiator comprises 1-hydroxycyclohexyl phenyl ketone, 2,2-dimethoxy-2-phenylacetophenone, 2-methyl-1-[4-(-methylthio)phenyl]-2-4-morpholinyl)-1-propanone, hydroxyacetophenone, phosphineoxide, benzophenone, or lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP). 17. The bio-ink of claim 13 , wherein the first filler component of freeze-dried cells are microbes, wherein the microbes are selected from the group consisting of bacteria, algae, fungi, protozoa, and a mixture thereof. 18. The bio-ink of claim 13 , wherein the first filler component of freeze-dried cells has a cell density of at least about 20 vol % or more of the total volume of the bio-ink. 19. The bio-ink of claim 13 , wherein the first filler component of freeze-dried cells has a cell density of at least about 40 vol % or more of the total volume of the bio-ink. 20. The bio-ink of claim 13 , wherein the first filler component of freeze-dried cells has a cell density of at least about 60 vol % or more of the total volume of the bio-ink.

Assignees

Inventors

Classifications

  • Materials specially adapted for additive manufacturing · CPC title

  • using only liquids or viscous materials, e.g. depositing a continuous bead of viscous material · CPC title

  • Processes of additive manufacturing · CPC title

  • Fillers · CPC title

  • Ethanol, i.e. non-beverage · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12404413B2 cover?
Bio-ink comprising freeze-dried cells, methods of making a living structure from a bio-ink material of freeze-dried cells, and methods of using the living structure for biosensing, tissue regeneration, environment sensing, drug discovery, catalysis, and/or clinical implementation are described herein.
Who is the assignee on this patent?
L Livermore Nat Security Llc
What technology area does this patent fall under?
Primary CPC classification C09D11/03. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).